Business
Medicenna Announces Trading on the OTCQX Best Market in the United States
Medicenna Announces Trading on the OTCQX Best Market in the United States Canada N...
About this update from Medicenna Therapeutics Corp.
[{"type":"text","content":"\n\n\n\nMedicenna Announces Trading on the OTCQX Best Market in the United States\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTORONTO and HOUSTON, TX, Oct. 18, 2017\n\n\n\nTORONTO and HOUSTON, TX, Oct. 18, 2017 /CNW/ - Medicenna Therapeutics Corp. (\"Medicenna\" or the \"Company\") (TSX: MDNA; OTCQX: MDNAF), a clinical stage immuno-oncology company, is pleased to announce that the Company has received approval to commence trading on the OTCQX Best Market, under the symbol, \"MDNAF\".  The Company's shares continue to trade on the Toronto Stock Exchange (\"TSX\") under the symbol \"MDNA\".\n\n\n\nOTCQX is an established market for global and growth companies with high financial standards. Investors can find current financial disclosure and Real-Time Level 2 quotes for Medicenna at www.otcmarkets.com.\n\n\"We are very pleased to be trading on the OTCQX as it will improve the Company's ability to attract a wider audience of investors from both inside and outside the United States. This corporate milestone will provide additional visibility within the investment community enabling us to build awareness more broadly and expand our current shareholder base in order to drive shareholder value\", said Elizabeth Williams, Chief Financial Officer of Medicenna. \n\n\"Medicenna Therapeutics joins an impressive roster of Canadian companies, including more than 25 added this year, that cross-trade their shares on the OTCQX market to maximize their reach to U.S. investors. Trading on OTCQX will enable Medicenna to efficiently broaden accessibility to their news and financial disclosure and build visibility among U.S. investors,\" said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. \n\nMedicenna Therapeutics was sponsored for OTCQX by Burns Figa & Will PC, a qualified third-party firm responsible for providing guidance on OTCQX requirements and recommending membership.  \n\nAbout Medicenna Therapeutics Corp. Medicenna is a clinical stage immuno-oncology company developing novel highly selective versions of...